Phase II study of chemoradiation plus bevacizumab (BV) for locally/regionally advanced nasopharyngeal carcinoma (NPC): Preliminary clinical results of RTOG 0615.
N. Y. Lee
No relevant relationships to disclose
Q. E. Zhang
No relevant relationships to disclose
A. S. Garden
No relevant relationships to disclose
J. J. Kim
No relevant relationships to disclose
D. G. Pfister
No relevant relationships to disclose
J. Mechalakos
No relevant relationships to disclose
K. Hu
No relevant relationships to disclose
Q. Le
No relevant relationships to disclose
B. S. Glisson
No relevant relationships to disclose
A. T. C. Chan
No relevant relationships to disclose
K. K. Ang
No relevant relationships to disclose